logo
AAT Bioquest

 
search
logo
AAT Bioquest
Contact us
Company
Telephone:1-408-733-1055
Fax:1-408-733-1304
Hours:Monday to Friday
8:30 - 17:30 PST (GMT-8)
Location:5775 W Las Positas Blvd.
Pleasanton, CA, 94588
USA

Email us
Sales:sales@aatbio.com
Technical Support:support@aatbio.com
Website:websupport@aatbio.com
General Inquiries:info@aatbio.com
Order info
United States of America
Telephone:1-408-733-1055
Fax:1-408-733-1304
Email:sales@aatbio.com
Purchase Order:sales@aatbio.com

International
Click here to see all available distributors
 
search
calculatorCalculator

Neurokinin 1 receptor Inhibitors (IC50, Ki)

Structure
▲
▼
Compound Name
▲
▼
Standard Type
▲
▼
Standard Values (in nM)
▲
▼
2-(Diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1-azabicyclo(2.2.2)octan-3-amineIC502.0 [1]
2-(Diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1-azabicyclo(2.2.2)octan-3-amineKi0.3 [1], 0.4 [2], 1.1 [3], 3.1 [4]
3-(2-Methoxybenzylamino)-2-phenylpiperidineIC500.2 [1], 0.6 [2]
3-(2-Methoxybenzylamino)-2-phenylpiperidineKi0.17 [1]
3,5-Bis(trifluoromethyl)benzyl N-acetyltryptophanIC501.6 [1]
3,5-Bis(trifluoromethyl)benzyl N-acetyltryptophanKi0.73 [1]
AprepitantIC500.09 [1]
AprepitantKi0.08 [1], 0.8 [2], 3.0 [3]
Substance PIC500.26 [1]
Substance PKi1.6 [1]
(2S,3S)-2-Benzhydryl-3-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-1-azabicyclo[2.2.2]octaneIC500.2 [1], 1.3 [2]
4-(3,5-Bis-trifluoromethyl-benzyloxymethyl)-4-phenyl-piperidineIC501.0 [1]
Bhsar-SPIC500.11 [1], 0.24 [2], 0.32 [3], 2.1 [4]
TalnetantKi10000.0 [1], 12589.25 [2], 100000.0 [3]
(2-Benzhydryl-1-aza-bicyclo[2.2.2]oct-3-yl)-benzyl-amineIC500.09 [1], 16.0 [2], 28.84 [3], 110.0 [4], 150.0 [5]
(6R,7S,8S)-6-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-7-(4-fluorophenyl)-1,2,5,6,7,8-hexahydropyrrolizin-3-oneIC500.06 [1], 2.2 [2]
(2S,3S)-2-Benzhydryl-3-[(3,5-dimethylphenyl)methoxy]-1-azabicyclo[2.2.2]octaneIC501.0 [1], 2.0 [2], 196.0 [3], 295.12 [4]
(4S,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-37-[[(2S)-2-[(2-Aminoacetyl)amino]propanoyl]amino]-34-(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-19-[(4-fluorophenyl)methyl]-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acidIC5044.0 [1], 1400.0 [2], 2700.0 [3], 3600.0 [4], 8200.0 [5]
[(2R,4S)-2-Benzyl-4-(quinolin-4-ylmethylamino)piperidin-1-yl]-(3,5-dimethylphenyl)methanoneIC5012.0 [1], 13.0 [2], 55.0 [3]
VofopitantIC500.08 [1]
VofopitantKi0.03 [1], 0.05 [2]
CP-122721IC500.14 [1], 0.19 [2], 0.4 [3]
VestipitantIC500.25 [1]
VestipitantKi0.22 [1], 0.25 [2]
3-[[(2S,3S)-2-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-3-phenylmorpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-oneIC500.09 [1]
(2S,3S)-N-[[2-Methoxy-5-(tetrazol-1-yl)phenyl]methyl]-2-phenylpiperidin-3-amineIC500.04 [1], 0.06 [2]
(2S,3S)-N-[[2-Methoxy-5-(tetrazol-1-yl)phenyl]methyl]-2-phenylpiperidin-3-amineKi0.04 [1], 0.05 [2]
Unii-QK6iajla0MIC500.55 [1], 1.0 [2], 1.05 [3], 5.9 [4]
SerlopitantIC500.06 [1], 9.5 [2]
(3,5-Dimethylphenyl)methyl (2S)-2-acetamido-3-(1H-indol-3-yl)propanoateIC5052.48 [1], 67.0 [2]
1-[(4Z)-5-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-3-(3,4-dichlorophenyl)-4-methoxyiminopentyl]-4-phenylpiperidin-4-olKi25.0 [1]
N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-N,7-dimethyl-5-(4-methylphenyl)-8-oxo-1,7-naphthyridine-6-carboxamideIC500.24 [1], 0.34 [2], 1.4 [3], 7.0 [4]
(2R)-2-[[(2S)-2-Amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(4S)-2-[2-[[3,5-bis(trifluoromethyl)phenyl]methyl-methylamino]-2-oxoethyl]-3-oxo-4,5-dihydro-1H-2-benzazepin-4-yl]-5-(diaminomethylideneamino)pentanamideKi0.5 [1], 7.8 [2]
(S)-1-(1H-Indol-3-yl)-2-(acetylamino)-5-[3,5-bis(trifluoromethyl)phenyl]-3-pentanoneIC502.2 [1], 3.09 [2], 3.1 [3], 10.0 [4]
N-[(2S)-5-[3,5-Bis(trifluoromethyl)phenyl]-1-(1H-indol-3-yl)-3-oxopentan-2-yl]-4-morpholin-4-ylbutanamideIC500.17 [1], 0.24 [2], 1.4 [3]
3-((E)-3-Carboxy-3-phenyl-allyl)-4,6-dichloro-1H-indole-2-carboxylic acidIC503.0 [1], 3.11 [2], 10000.0 [3]
3-((E)-3-Carboxy-3-phenyl-allyl)-4,6-dichloro-1H-indole-2-carboxylic acidKi0.3 [1]
(6R,7S,8R)-1-Amino-6-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-7-(4-fluorophenyl)-1,2,5,6,7,8-hexahydropyrrolizin-3-oneIC500.09 [1], 0.11 [2], 0.6 [3], 1.8 [4]
(6R,7S,8S)-2-Amino-6-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-7-(4-fluorophenyl)-1,2,5,6,7,8-hexahydropyrrolizin-3-oneIC500.06 [1], 0.38 [2]
2-[(2S,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidin-1-yl]acetamideIC501.0 [1], 1.29 [2], 1.3 [3]
(4S,7S,10S,13S,16S,19S,22R,25S,28S,31S,34S,37R)-37-[[(2S)-2-[(2-Aminoacetyl)amino]propanoyl]amino]-34-(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-19-[(4-fluorophenyl)methyl]-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acidIC50220.0 [1], 240.0 [2], 950.0 [3], 6100.0 [4]
(4S,7S,10S,13S,16S,19S,22R,25S,28S,31S,34S,37R)-37-Amino-34-(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-19-[(4-fluorophenyl)methyl]-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acidIC50250.0 [1], 260.0 [2], 900.0 [3], 9600.0 [4]
Neurokinin BIC5097.5 [1], 98.0 [2]
Neurokinin BKi501.19 [1]
SenktideIC5010000.0 [1]
SenktideKi10000.0 [1]
(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]-N-[(2S)-1-[[(2S)-1-[[3,5-bis(trifluoromethyl)phenyl]methylamino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamideIC500.01 [1]
(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]-N-[(2S)-1-[[(2S)-1-[[3,5-bis(trifluoromethyl)phenyl]methylamino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamideKi0.01 [1]
1H-Indole, 2-(4-bromophenyl)-3-[3-[4-(2-methoxyphenyl)-1-piperazinyl]-3-oxopropyl]-5-methyl-IC501.0 [1]
5-{3,4,5-Tris-benzyloxy-6-[2-(1H-indol-3-yl)-ethoxy]-tetrahydro-pyran-2-ylmethoxy}-pentylamineIC50120.0 [1], 120000.0 [2]
5-{3,4,5-Tris-benzyloxy-6-[2-(1H-indol-3-yl)-ethoxy]-tetrahydro-pyran-2-ylmethoxy}-pentylamineKi150.0 [1]
3-[[(2S,3S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidin-1-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-oneIC500.05 [1], 0.1 [2]
4-Benzyloxymethyl-4-phenyl-piperidineIC501096.48 [1], 1100.0 [2], 1113.0 [3]
2-Dimethylamino-3-(1H-indol-3-yl)-propionic acid 3,5-dimethyl-benzyl esterIC50549.54 [1], 553.0 [2]
4-(3,5-Dimethyl-benzyloxymethyl)-4-phenyl-piperidineIC508.91 [1], 9.0 [2], 9.1 [3]
(3,5-Dimethylphenyl)methyl (2S)-2-benzamido-3-(1H-indol-3-yl)propanoateIC5021.88 [1], 22.0 [2]
1-[(4E)-5-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-3-(3,4-dichlorophenyl)-4-methoxyiminopentyl]-4-phenylpiperidin-4-olKi25.0 [1]
4-Phenyl-4-(3-trifluoromethyl-benzyloxymethyl)-piperidineIC5057.0 [1], 57.54 [2]
(2-Benzhydryl-1-aza-bicyclo[2.2.2]oct-3-yl)-(2-methoxy-benzyl)-amineIC500.33 [1], 41.0 [2], 81000.0 [3]
[3,5-Bis(trifluoromethyl)phenyl]methyl (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoateIC500.13 [1], 0.95 [2]
[3,5-Bis(trifluoromethyl)phenyl]methyl (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoateKi0.08 [1]
2-({[3,5-Bis(trifluoromethyl)phenyl]methoxy}methyl)-2-phenylpiperidineIC501.0 [1]
2-({[3,5-Bis(trifluoromethyl)phenyl]methoxy}methyl)-2-phenylpiperidineKi1.0 [1]
(S,3S)-3-[5-(1,1-Dimethyl-2,2,2-trifluoroethyl)-2-methoxybenzylamino]-2-phenylpiperidineIC500.2 [1], 0.3 [2]
1-Benzofuran-2-ylmethyl N-[(2S)-2-[(dimethylamino)methyl]-3-(1H-indol-3-yl)-1-oxo-1-[[(1S)-1-phenylethyl]amino]propan-2-yl]carbamateIC500.46 [1], 0.5 [2], 5.5 [3]
N-[[3,5-Bis(trifluoromethyl)phenyl]methyl]-4-[4-(4-fluorophenyl)piperidin-1-yl]-1-phenylcyclohexane-1-carboxamideIC500.34 [1], 150.0 [2]
(2R,3R)-2-Benzhydryl-3-(3,5-bis-trifluoromethyl-benzyloxy)-1-aza-bicyclo[2.2.2]octaneIC50300.0 [1], 570.0 [2], 575.44 [3]
(2R,3S)-2-Benzhydryl-3-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-1-azabicyclo[2.2.2]octaneIC500.2 [1], 0.7 [2], 0.71 [3]
2-Methyl-4-phenyl-quinoline-3-carboxylic acid 3,5-bis-trifluoromethyl-benzylamideIC500.07 [1], 257.0 [2], 3900.0 [3]
(2R)-2-[[(2S)-2-Amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(4S)-2-[3-[benzyl(methyl)amino]-3-oxopropyl]-3-oxo-4,5-dihydro-1H-2-benzazepin-4-yl]-5-(diaminomethylideneamino)pentanamideKi6.44 [1], 13.0 [2]
2-[[(2S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-1,1-diphenylpropan-2-yl]amino]acetamideIC500.52 [1], 0.53 [2]
2-[[(2S)-3-[[3,5-Bis(trifluoromethyl)phenyl]methoxy]-1,1-diphenylpropan-2-yl]amino]acetamideKi0.9 [1]
(2S,3S,3Ar,6aS)-N-(2-methoxybenzyl)-2-phenyl-octahydrocyclopenta[b]pyrrol-3-amineIC502.4 [1], 3.4 [2]
(2S,3S,3Ar,6aS)-N-(2-methoxybenzyl)-2-phenyl-octahydrocyclopenta[b]pyrrol-3-amineKi2.4 [1]
N-[(2S)-5-[3,5-Bis(trifluoromethyl)phenyl]-1-(1H-indol-3-yl)-3-oxopentan-2-yl]-2-pyridin-4-ylacetamideIC500.4 [1], 0.5 [2], 10.0 [3]
2-Benzylidene-3-(3,5-dimethyl-benzyloxy)-1-aza-bicyclo[2.2.2]octaneIC502933.0 [1], 7500.0 [2], 8200.0 [3]
(2E)-2-Benzylidene-3-[(3,5-dimethylphenyl)methoxy]-1-azabicyclo[2.2.2]octaneIC50120.0 [1], 129.0 [2], 615.0 [3]
(S)-1-(1H-Indol-3-yl)-2-[(morpholinoacetyl)amino]-5-[3,5-bis(trifluoromethyl)phenyl]-3-pentanoneIC502.0 [1], 3.5 [2], 4.0 [3]
1-(3,5-Dimethyl-benzyloxymethyl)-2,2-diphenyl-ethylamineIC509.3 [1]
1-(3,5-Bis-trifluoromethyl-benzyloxymethyl)-2,2-diphenyl-ethylamineIC5010.7 [1]
2-[1-(3,5-Bis-trifluoromethyl-benzyloxymethyl)-2,2-diphenyl-ethylamino]-acetamideIC500.53 [1], 0.85 [2]
2-[3,5-Bis(trifluoromethyl)phenyl]-N-[4-(4-fluoro-2-methylphenyl)-6-[(2R,3S)-3-hydroxy-2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl]-N,2-dimethylpropanamideKi0.7 [1], 1.1 [2]
(2S)-1-[(4Ar)-1-oxo-4,4-diphenyl-2,3,4a,5,7,7a-hexahydrothiopyrano[2,3-c]pyrrol-6-yl]-2-(2-methoxyphenyl)propan-1-oneIC5022.91 [1], 23.0 [2], 49.0 [3]
(2S,3S)-2-Benzhydryl-3-[[3-(trifluoromethyl)phenyl]methoxy]-1-azabicyclo[2.2.2]octaneIC5053.0 [1], 2100.0 [2]
N-[(2S)-5-[3,5-Bis(trifluoromethyl)phenyl]-1-(1H-indol-3-yl)-3-oxopentan-2-yl]-1-azabicyclo[2.2.2]octane-4-carboxamideIC500.9 [1], 1.0 [2], 8.0 [3]
[(2S,4R)-2-Benzyl-4-(quinolin-4-ylmethylamino)piperidin-1-yl]-(3,5-dimethylphenyl)methanoneIC50130.0 [1], 690.0 [2]
SaredutantIC50593.0 [1], 800.0 [2]
7,7-Diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-oneIC5030.0 [1], 49.0 [2]
(R)-(2-Methoxy-benzyl)-((S)-2-phenyl-piperidin-3-yl)-amineIC500.5 [1]
(R)-(2-Methoxy-benzyl)-((S)-2-phenyl-piperidin-3-yl)-amineKi0.17 [1]
CasopitantKi0.13 [1], 0.33 [2]
NetupitantIC500.95 [1]
NetupitantKi0.95 [1]
LanepitantIC500.15 [1], 0.23 [2]
SB 218795Ki100000.0 [1]
Unii-qrt7W0TL6XIC500.45 [1]
DapitantIC5013.0 [1], 13000.0 [2]
Items per page: 1 - 10 of 97
⟨⟩

References

This online tool may be cited as follows

MLA

"Quest Database™ Neurokinin 1 receptor Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/neurokinin-1-receptor-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024, November 21). Quest Database™ Neurokinin 1 receptor Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/neurokinin-1-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan